Research Opportunities
We want to help kidney cancer researchers locate funding opportunities. We’ll update this page with grant opportunities as we learn about them. Know of one we haven’t listed? Email us at [email protected], or tweet at us, and we’ll get it posted!
KidneyCAN is dedicated to accelerating kidney cancer research.
Our advocacy for the DoD Kidney Cancer Research Program resulted in appropriations of $40 million in fiscal year 2020 for kidney cancer research. In 2016, this number was $0.
Our Kidney Cancer Research Summit brings translational researchers in kidney cancer together in an annual collaborative meeting. Additionally, KidneyCAN’s “Rock the Cure” events have raised over $1,000,000 toward private research support.
We are reaching out to you to create the best ideas yet for your KCRP proposal this year.
Please share this notice with other researchers in your network.
- Develop your ideas
- Build your team – even including members from other institutions
- Gather letters of support
- Review the grant mechanisms (including the new ones) and consider which would best support your idea
- Consider partnerships (including industry partnerships) and collaborations
FY21 KCRP Program Announcements Released
As new announcements are posted we will keep you updated.
Translational Research Partnership Award
Idea Development Award
Postdoctoral and Clinical Fellowship Award
AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants
The AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants represents a joint effort to stimulate “high-risk, high-reward” research from early- to mid-career investigators. This novel grant mechanism is intended to promote and support creative, paradigm-shifting cancer research that might not be funded through conventional channels. It is expected that these grants will catalyze significant scientific discoveries that will advance our understanding of cancer and have a potentially transformative impact on future clinical practice.
The application is due on September 30, 2021.
AACR: New Funding Opportunities
We’d love to see more RCC applicants for these prestigious grant opportunities. AACR has just updated their site with this note:
We hope you and your loved ones are well, given the difficult circumstances surrounding the COVID-19 pandemic. Please note that several funding opportunities are currently under development. Although we expect that the process may likely take longer than originally expected, please know that our team is working diligently to ensure that the new grants will be launched at the earliest possible date. We are closely monitoring the situation and will post upcoming funding opportunities here once a launch date has been confirmed.
However, if you have specific questions or concerns, please feel free to contact [email protected].
Sincerely,
The Scientific Review and Grants Administration Team
KidneyCAN is proud to present the 3rd Annual Kidney Cancer Research Summit on October 7 & 8, 2021. KCRS is a meeting focused on basic, translational, and clinical kidney cancer research. This meeting is fueled by the ideas and research funded through the Department of Defense CDMRP-KCRP awards.
The goal for KCRS is to present the important, innovative research funded by the KCRP. We also aim to connect researchers from around the world to share their work.
Kidney cancer is the ideal sandbox for these new approaches, and without a doubt the same approach can, should and will be suitable for other cancers.
Dr. Hans Hammers, UTSW
RESEARCH UPDATES
Fall Micro-Strike: KidneyCAN Asks Congress to Fund Kidney Cancer Research
Fall Micro-Strike: KidneyCAN Asks Congress to Fund Kidney Cancer ResearchOn Monday, December 1, 2021, KidneyCAN gathered a team of delegates and once again asked Congress to fund kidney cancer research. We are asking for robust funding of the Congressionally Directed...
District Days 2021: Speaking with One Voice
Our Ask: Fund Kidney Cancer Research We lose almost 40 people per day to kidney cancer in the United States. The need for research funding is urgent.For District Days, the kidney cancer community met with members of Congress all over the United States to ask for...
Dr. John T. Wilson: “A Lot of Reason to Hope”
Researcher Spotlight: Dr. John T. Wilson Giving Patients "A Lot of Reason to Hope" At KidneyCAN, we have the pleasure of meeting and working with talented researchers from all over the world. We want to share some of the insights and experiences of one such researcher...
Join Our Grassroots Army
;
#WCRM is meeting again for first time in the new year, ready to present our kidney cancer research at #GU22 next month whether virtually or in person @DanaFarber_GU
1/ Happy to share with you our analysis of PROs/QOLs from the CheckMate-9ER trial of Nivo+Cabo vs. Sun. in patients with metastatic #RCC, just published in @TheLancetOncol
@CellaDavid @motzermd @apolo_andrea @DanaFarber_GU @OncoAlert
https://www.sciencedirect.com/science/article/pii/S1470204521006938?dgcid=coauthor
Excited to join the Beijing anti-cancer association’s Beijing GU oncology updates conference w/ good friends @neerajaiims @PGrivasMDPhD & me giving the keynotes in #prostatecancer, #bladdercancer & #kidneycancer this evening. A true privilege to visit my hometown virtually.
Congratulations, @BraunMDPhD! Look forward to watching your great work unfold at @YaleCancer @YaleMed 👏👏👏
Officially settling in here @YaleCancer @YaleMed, and I am grateful for the warm welcome!
If you are interested in cancer immunotherapy, translational research, genomics, or kidney cancer, please contact me ([email protected]). We are hiring at all levels (postgrad, MS, PhD)!
Truly honored to be in this lineup of great people working to #acceleratecures for #kidneycancer and #GUcancers!
Thank you to @weoncologists and the @OncoAlert #OncoAlertColloquium for allowing us to share about KidneyCAN’s advocacy and #KCRS.
Thanks for Joining us for DAY1⃣of our #OncoAlertColloquium 🚨
🙏 @DrChoueiri @apolo_andrea @neerajaiims @piet_ost @seanmmcbride @kidneycan @SIOGorg @ravikanesvaran & @nicolobattisti
This Video📺is NOW Available‼️
JUST CLICK
https://www.youtube.com/watch?v=razFoXCU03k
or http://www.OncoAlert360.com
@TiansterZhang @PGrivasMDPhD @DrChoueiri @Daniel_J_George @utswcancer @UTSWHemeOnc @montypal @Huntsman_GU @fredhutch @Zihai @OncoAlert @HHammersMD @KCA_Journal @kidneycan @IKCCorg @umangtalking @nsayeghmd @TripNish Personalizing medicine in metastatic #kidneycancer : ongoing approaches and trials. Excellent overview by @TiansterZhang at Beijing GU oncology update.
@TiansterZhang @PGrivasMDPhD @DrChoueiri @Daniel_J_George @utswcancer @UTSWHemeOnc @montypal @Huntsman_GU @fredhutch @Zihai Always enjoy the wonderful talks by @TiansterZhang 👉first line metastatic RCC #kidneycancer trials, summary and future directions. @PGrivasMDPhD This one at the Beijing GU oncology conference. Mentioning @DrChoueiri @OncoAlert
Critical findings from @DrChoueiri et al, illustrating the importance of protecting #cancer patients from #COVID19.
ACS strongly endorses the recommendation for vaccination of close contacts, boosters, social distancing, & masking. @AmericanCancer https://bit.ly/32Nn5AB
@ZiadBakouny @CellReports @srviswanathan @DrChoueiri @VanAllenLab @BrighamResearch @DanaFarberNews @broadinstitute @harvardmed @Sadagopan_A @anotherpathres @LabSignoretti @Chrislabaki1 @BraunMDPhD @stephentang23 @kidneycan @KidneyCancer @urotoday @DrDanielHeng Congratulations, Ziad!! Such a nice study and I am glad that I heard part of it previously at #KCRS21
Ecstatic to see our work on tRCC now published in @CellReports!
Incredibly thankful to my mentors @srviswanathan, @DrChoueiri, @VanAllenLab & all co-authors
@BrighamResearch @DanaFarberNews @broadinstitute @harvardmed
Link: https://www.cell.com/cell-reports/fulltext/S2211-1247(21)01691-0?_returnURL=https://linkinghub.elsevier.com/retrieve/pii/S2211124721016910%3Fshowall%3Dtrue https://twitter.com/ZiadBakouny/status/1478429240748126209/photo/1 https://twitter.com/ZiadBakouny/status/1383132786425466888
1/ Just posted on @biorxivpreprint!
Thrilled be sharing our work on translocation Renal Cell Carcinoma (tRCC).
Huge thanks to mentors @srviswanathan, @DrChoueiri & @VanAllenLab & all co-authors.
@DanaFarber @broadinstitute @harvardmed
A Thread (1/15)!
https://www.biorxiv.org/content/10.1101/2021.04.14.439908v1
KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Programs (CDMRP) or KCRP (Kidney Cancer Research Program). Our work is funded by grassroots donors in the kidney cancer community.
